The effects of pyridinolcarbamate on induced atherosclerosis in cynomolgus monkeys (Macaca ira).
D000818:Animals; D001011:Aorta / Q000473:pathology; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000473:pathology; D002219:Carbamates / Q000008:administration & dosage* / Q000627:therapeutic use; D002784:Cholesterol / Q000494:pharmacology; D003327:Coronary Disease / Q000188:drug therapy*; D003331:Coronary Vessels / Q000473:pathology; D004036:Diet, Atherogenic; D005260:Female; D000882:Haplorhini; D008251:Macaca; D000432:Methanol / Q000008:administration & dosage / Q000627:therapeutic use; D011725:Pyridines / Q000008:administration & dosage / Q000627:therapeutic use; D013194:Staining and Labeling
D002219:Carbamates; D011725:Pyridines; D002784:Cholesterol; D000432:Methanol